Day One Biopharma stock gains on BofA upgrade (NASDAQ:DAWN)
Pgiam/iStock via Getty Images Day One Biopharmaceuticals (NASDAQ:DAWN) traded higher on Thursday after Bank of America upgraded the cancer drugmaker…
Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update By Investing.com
LUND, Sweden, July 18, 2024 /PRNewswire/ -- Hansa Biopharma today announced its first half and second quarter 2024 financial results…
2023 shaping up to be biggest year for biopharma M&A since pandemic (NYSE:PFE)
Maksim Labkouski The IPO market may still be frigid, but 2023 is shaping up to be the biggest year for…
